GXMC
AEGR

Global X Management Company’s Aegerion Pharmaceuticals AEGR Stock Holding History

Global X Management Company’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-399
Closed -$18K – 569
2014
Q1 		$18K Buy
+399
New +$23.4K ﹤0.01% 517

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Global X Management Company's AEGR Position: Q2 2014 in Review

Global X Management Company sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2014, closing a stake of 399 shares — an estimated $18K sold.

Global X Management Company first reported a position in AEGR in Q1 2014 and held it in 1 quarter. The position peaked at $18K in Q1 2014. 129 funds tracked by Wall St. Rank hold AEGR as of Q2 2014.

  • Global X Management Company reported no remaining Aegerion Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Global X Management Company sold 399 Aegerion Pharmaceuticals shares in Q2 2014, an estimated $18K.
  • Global X Management Company first reported a position in Aegerion Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Global X Management Company's Aegerion Pharmaceuticals position peaked at $18K in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2014.

Based on Global X Management Company's 13F filing for Q2 2014, filed 31 Jul 2014.